PI3K signalling: the path to discovery and understanding

被引：0

作者：

Bart Vanhaesebroeck

Len Stephens

Phillip Hawkins

机构：

[1] Bart Vanhaesebroeck is at the Centre for Cell Signalling,

[2] Barts Cancer Institute,undefined

[3] Queen Mary University of London,undefined

[4] Charterhouse Square,undefined

[5] London EC1M 6BQ,undefined

[6] United Kingdom.,undefined

[7] Len Stephens and Phillip Hawkins are at the Inositide Laboratory,undefined

[8] The Babraham Institute,undefined

[9] Cambridge CB22 3AT,undefined

[10] United Kingdom.,undefined

来源：

Nature Reviews Molecular Cell Biology | 2012年 / 13卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Phosphoinositide 3-kinase (PI3K) signalling is central in the regulation of cellular function. Here, Vanhaesebroecket al.review the key discoveries that led the identification of the PI3K genes and function to the design of clinical trials with PI3K inhibitors, over a period of less than three decades.

引用

页码：195 / 203

页数：8

共 50 条

[1] PI3K signalling: the path to discovery and understanding
Vanhaesebroeck, Bart
Stephens, Len
Hawkins, Phillip
[J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (03) : 195 - 203
[2] PI3K signalling in inflammation
Hawkins, P. T.
Stephens, L. R.
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2015, 1851 (06): : 882 - 897
[3] Dermatological implications of the PI3K path
Dereure, O.
[J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2015, 142 (10): : 622 - 623
[4] Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective
Lucinda J. Berglund
[J]. Journal of Clinical Immunology, 2024, 44
[5] Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective
Berglund, Lucinda J.
[J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (01)
[6] Nuclear PI3K signalling in colorectal cancer
Palmieri, M.
Catimel, B.
Holmes, A.
Sieber, O.
[J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S123 - S123
[7] New WAVEs in neuronal PI3K signalling
Mack, Till G. A.
Eickholt, Britta J.
[J]. EMBO JOURNAL, 2011, 30 (23): : 4693 - 4695
[8] PI3K/Akt signalling pathway and cancer
Vara, JAF
Casado, E
de Castro, J
Cejas, P
Belda-Iniesta, C
González-Barón, M
[J]. CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
[9] Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors
Ma, Chen-Chen
Zhang, Cheng-Mei
Tang, Long-Qian
Liu, Zhao-Peng
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 9 - 17
[10] Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors
Jia, Hong
Dai, Guangxiu
Su, Weiguo
Xiao, Kun
Weng, Jianyang
Zhang, Zhulin
Wang, Qing
Yuan, Tianhai
Shi, Fuying
Zhang, Zheng
Chen, Wei
Sai, Yang
Wang, Jian
Li, Xiong
Cai, Yu
Yu, Jun
Ren, Ping
Venable, Jennifer
Rao, Tadimeti
Edwards, James P.
Bembenek, Scott D.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4936 - 4948

← 1 2 3 4 5 →